Roche Holding AG (RHHBF)
428.24
-5.77
(-1.33%)
USD |
OTCM |
Sep 16, 16:00
Roche Market Cap : 341.21B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 341.21B |
| September 15, 2026 | 345.80B |
| September 14, 2026 | 345.80B |
| September 11, 2026 | 345.00B |
| September 10, 2026 | 345.00B |
| September 09, 2026 | 358.54B |
| September 08, 2026 | 358.54B |
| September 04, 2026 | 351.69B |
| September 03, 2026 | 351.69B |
| September 02, 2026 | 351.69B |
| September 01, 2026 | 347.79B |
| August 31, 2026 | 361.56B |
| August 28, 2026 | 363.74B |
| August 27, 2026 | 367.29B |
| August 26, 2026 | 372.09B |
| August 25, 2026 | 382.45B |
| August 24, 2026 | 372.97B |
| August 21, 2026 | 372.97B |
| August 20, 2026 | 370.50B |
| August 19, 2026 | 366.09B |
| August 18, 2026 | 350.58B |
| August 17, 2026 | 356.58B |
| August 14, 2026 | 353.51B |
| August 13, 2026 | 363.23B |
| August 12, 2026 | 363.23B |
| Date | Value |
|---|---|
| August 11, 2026 | 368.05B |
| August 10, 2026 | 367.56B |
| August 07, 2026 | 352.45B |
| August 06, 2026 | 343.54B |
| August 05, 2026 | 346.98B |
| August 04, 2026 | 358.45B |
| August 03, 2026 | 339.29B |
| July 31, 2026 | 337.19B |
| July 30, 2026 | 338.68B |
| July 29, 2026 | 356.60B |
| July 28, 2026 | 357.10B |
| July 27, 2026 | 346.59B |
| July 24, 2026 | 348.98B |
| July 23, 2026 | 342.61B |
| July 22, 2026 | 338.78B |
| July 21, 2026 | 330.66B |
| July 20, 2026 | 332.25B |
| July 17, 2026 | 346.59B |
| July 16, 2026 | 337.83B |
| July 15, 2026 | 327.63B |
| July 14, 2026 | 327.63B |
| July 13, 2026 | 329.26B |
| July 10, 2026 | 342.61B |
| July 09, 2026 | 334.90B |
| July 08, 2026 | 334.90B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 258.00B |
| GSK Plc | 103.30B |
| Merck & Co., Inc. | 363.30B |
| Pfizer Inc. | 157.46B |
| Addex Therapeutics Ltd. | 3.341M |
Market Cap Related Metrics
| PE Ratio | 22.15 |
| PS Ratio | 4.488 |
| PEG Ratio | 0.7429 |
| Price to Free Cash Flow | 21.06 |
| Price | 428.24 |
| Earnings Yield | 4.52% |
| PEGY Ratio | 0.6708 |
| Operating PE Ratio | 14.64 |
| Normalized PE Ratio | 18.56 |